V

Verastem
D

VSTM

4.81500
USD
-0.06
(-1.13%)
مغلق
حجم التداول
55,793
الربح لكل سهم
-3
العائد الربحي
-
P/E
-1
حجم السوق
264,580,254
أصول ذات صلة
A
ARRY
0.80000
(11.51%)
7.75000 USD
B
BPMC
0.130
(0.10%)
128.340 USD
C
CRSP
0.455
(0.88%)
52.120 USD
E
EXEL
1.840
(4.15%)
46.150 USD
INCY
INCY
0.300
(0.44%)
68.470 USD
المزيد
الأخبار المقالات

العنوان: Verastem

القطاع: Healthcare
الصناعة: Biotechnology
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer thatpromote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.